Venture-Backed Startups

BioLogiQ makes plant-based thermoplastic resins (BioPolymers such as NuPlastiQ, DuraPlantiQ, and BioBlend) that convert starch into plastic resins for manufacturers to blend with traditional plastics, reducing plastic pollution and improving recycled and compostable content. Its products serve manufacturers seeking more sustainable, planet-friendly plastic materials.

0 investors

Biologos is a custom biologics contract manufacturer producing GMP-compliant, ISO 13485:2016 certified products such as cell culture media (e.g. DMEM) and buffers (e.g. Tris Buffer). It serves cell and gene therapy, biopharma, diagnostics, tissue processing, and CDMO/CMO customers.

1 investor

Biolojic uses machine learning to design programmable human antibodies, including epitope-specific binders and multi-specific "multibodies," that act as functional switches targeting validated biological pathways. Its drug pipeline focuses on treatments for autoimmune diseases and immuno-oncology.

3 investors

1 investor

Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.

1 investor

Uses UV light signals to boost seed and seedling genetic potential; domiciled in the USA.

8 investors

0 investors

Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.

1 investor

0 investors

Biom makes plastic-free cleaning and personal-care wipes—including disinfecting, flushable, all-purpose, body, hand sanitizing, and baby wipes—using 100% plant-based fibers, along with refillable dispensers and shippable refills to reduce plastic waste. The brand sells directly to consumers for home cleaning and personal hygiene.

4 investors

0 investors

Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.

1 investor

0 investors

0 investors

Biomarq Health develops a wearable, injectable multi-analyte biosensor platform that continuously monitors biochemical markers such as glucose, lactate, ketones, cortisol, and kidney-related analytes from a single sensor. Its first product targets affordable continuous glucose monitoring for people with type 1, type 2, and pre-diabetes, with planned applications in chronic kidney disease, pregnancy monitoring, and healthspan research.

1 investor

Biomarx develops automated liquid biopsy diagnostics using biosensing technologies for early cancer and disease detection, delivering test results in under two hours at low cost. Its products target clinicians and healthcare providers seeking rapid, affordable precision diagnostics for personalised medicine.

1 investor

Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry. Founded in North Carolina with manufacturing and market development in Denmark, the company sells tile products installed in the US and Europe and is developing pavers and walls, with a focus on the European market.

3 investors

Biomass Controls builds decentralized sanitation systems, including the Biogenic Refinery, to process fecal sludge, septage, and biosolids in areas where centralized wastewater treatment is unavailable or not cost-effective. It targets low-resource and cold-climate settings such as Arctic communities in Alaska, peri-urban settlements in India, and off-grid industrial camps.

1 investor

Biomass Magazine is a trade publication and news outlet covering the biomass, renewable natural gas, and biofuel industries, reporting on projects, policy, and companies in the sector. It also produces industry events such as the International Biomass Conference & Expo and related podcasts.

1 investor

1 investor

0 investors

Creating proteins for health and manufacturing

2 investors

Biome makes Taiga, a smart hydroponic living wall with onboard sensors, automated irrigation, and lighting that automates indoor plant care, along with the Halo grow light, plant supplements, and a companion app to monitor and control the system. It sells soil-free, fully grown living walls for home consumers, shipped from its indoor vertical greenhouse in Oakland, CA.

1 investor

Biome provides analytics tools for healthcare leaders, focused on improving cardiovascular care outcomes and reducing operational inefficiency. It serves hospitals and cardiac care centers, offering data-driven products including the Biome Performance Network for clinical and operational decision-making.

0 investors